Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty

Clinical Orthopaedics and Related Research

Volumn 444, Issue , 2006, Pages 146-153

  Della Valle, Alejandro González ^a,b   Serota, Alana ^a   Go, George ^a   Sorriaux, Gregory ^c   Sculco, Thomas P ^a,b   Sharrock, Nigel E ^a,b   Salvati, Eduardo A ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PROCOAGULANT; WARFARIN; ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DISEASE PREDISPOSITION; EPIDURAL ANESTHESIA; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; TOTAL HIP PROSTHESIS; CLINICAL PROTOCOL; COHORT ANALYSIS; HIP ARTHROPLASTY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, EPIDURAL; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION, AUTOLOGOUS; CLINICAL PROTOCOLS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33645969614     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000201157.29325.f0     Document Type: Article

References (90)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
2. Anonymous. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295-1302.
3. Bae H, Westrich GH, Sculco TP, Salvati EA, Reich LM. The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg. 2001;83:676-679.
4. Barnes RW, Brand RA, Clarke W, Hartley N, Hoak JC. Efficacy of graded-compression antiembolism stockings in patients undergoing total hip arthroplasty. Clin Orthop Relat Res. 1978;132:61-67.
5. Binns M, Pho R. Femoral vein occlusion during hip arthroplasty. Clin Orthop Relat Res. 1990;255:168-172.
6. Bishop NE, Ferguson S, Tepic S. Porosity reduction in bone cement at the cement-stem interface. J Bone Joint Surg. 1996;78:349-356.
7. Callaghan JJ, Dorr LD, Engh GA, Hanssen AD, Healy WL, Lachiewicz PF, Lonner JH, Lotke PA, Ranawat CS, Ritter MA, Salvati EA, Sculco TP, Thornhill TS. Prophylaxis for thromboembolic disease. J Arthroplasty. 2005;20:273-274.
8. Christie J, Robinson CM, Pell AC, McBirnie J, Burnett R. Transcardiac echocardiography during invasive intramedullary procedures. J Bone Joint Surg. 1995;77:450-455.
9. Christie J, Robinson CM, Singer B, Ray DC. Medullary lavage reduces embolic phenomena and cardiopulmonary changes during cemented hemiarthroplasty. J Bone Joint Surg. 1995;77:456-459.
10. Clark JA, Bremner BR. Fatal warfarin-induced skin necrosis after total hip arthroplasty. J Arthroplasty. 2002;17:1070-1073.
11. Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: a randomized, double-blind study. J Thromb Haemost. 2003;1:2119-2130.
12. Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge. J Bone Joint Surg. 1999;81:932-940.
13. Dahl OE, Gudmundsen TE, Bjornara BT, Solheim DM. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients. Acta Orthop Scand. 2003;74:299-304.
14. Dall DM, Miles AW, Juby G. Accelerated polymerization of acrylic bone cement using preheated implants. Clin Orthop Relat Res. 1986;211:148-150.
15. DiGiovanni CW, Restrepo A, Gonzalez Della Valle AG, Sharrock NE, McCabe JP, Sculco TP, Pellicci PM, Salvati EA. The safety and efficacy of intraoperative heparin in total hip arthroplasty. Clin Orthop Relat Res. 2000;379:178-185.
16. Dripps RD. New classification of physical status. Anesthesiology. 1963;24:111.
17. FDA Public Health Advisory. Reports of epiudural or spinal hematomas with the concurrent use of low molecular weight heaprin and spinal/epidural anesthesia or spinal puncture. Washington, DC: U.S. Department of Health and Human Resources. December 15, 1997.
18. Fender D, Harper WM, Thompson JR, Gregg PJ. Mortality and fatal pulmonary embolism after primary total hip replacement: results from a regional hip register. J Bone Joint Surg. 1997;79:896-899.
19. Ferrari B, Baudouy M, Cerboni P. Clinical epidemiology of venous thromboembolic disease: results of a French multicenter registry. Eur Heart J. 1997;18:681-691.
20. Francis CW, Pellegrini VD Jr, Totterman S, Boyd AD Jr, Marder VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A, Kessler C, Johanson NA. Prevention of deep-vein thrombosis after total hip arthroplasty: comparison of warfarin and dalteparin. J Bone Joint Surg. 1997;79:1365-1372.
21. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg. 2000;82:929-938.
22. Gitel SN, Salvati EA, Wessler S, Robinson HJ Jr, Worth MH Jr. The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis. J Bone Joint Surg. 1979;61:653-656.
23. Gonzalez Della Valle A, Ruzo PS, Salvati EA. Warfarin-associated intracapsular hemorrhage causing an acutely painful total hip arthroplasty: a rare complication of prolonged anticoagulant therapy. J Arthroplasty. 2000;15:668-670.
24. Harris WH, Salzman EW, Athanasoulis C, Waltman AC, Baum S, DeSanctis RW. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg. 1974;56:1552-1562.
25. Hooker JA, Lachiewicz PF, Kelley SS. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg. 1999;81:690-696.
26. Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med. 2000;160:2199-2207.
27. Huo MH, Salvati EA, Sharrock NE, Brien WW, Sculco TP, Pellicci PM, Mineo R, Go G. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty: a prospective, randomized, controlled, clinical trial. Clin Orthop Relat Res. 1992;274:35-46.
28. Huo MH, Salvati EA, Sharrock NE, Pellicci PM, Sculco TP, Go G, Mineo R, Brien WW. Intraoperative adjusted-dose heparin thromboembolic prophylaxis in primary total hip arthroplasty. Clin Orthop Relat Res. 1992;277:188-196.
29. Iesaka K, Jaffe WL, Kummer FJ. Effects of preheating of hip prostheses on the stem-cement interface. J Bone Joint Surg. 2003;85:421-427.
30. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA. 1994;271:1780-1785.
31. Ivascu FA, Janczyk RJ, Bair HA, Bendick PJ, Howells GA. Spontaneous retroperitoneal hemorrhage. Am J Surg. 2005;189:345-347.
32. Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res. 1977;127:123-132.
33. Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. Chest. 1998;114(2 suppl evidence):115S-118S.
34. Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand. 2002;73:392-399.
35. Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg. 1994;76:341-348.
36. Lotke PA, Palevsky H, Keenan AM, Meranze S, Steinberg ME, Ecker ML, Kelley MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996;324:251-258.
37. Macaulay W, Westrich G, Sharrock N, Sculco TP, Jhon PH, Peterson MG, Salvati EA. Effect of pneumatic compression on fibrinolysis after total hip arthroplasty. Clin Orthop Relat Res. 2002;399:168-176.
38. Markel DC, Urquhart B, Derkowska I, Salvati EA, Sharrock NE. Effect of epidural analgesia on venous blood flow after hip arthroplasty. Clin Orthop Relat Res. 1997;334:168-174.
39. Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol. 2001;37:215-218.
40. Moll S. Warfarin-induced skin necrosis. Br J Haematol. 2004;126:628.
41. Murray DW, Britton AR, Bulstrode CJ. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg. 1996;78:863-870.
42. Nassif JM, Ritter MA, Meding JB, Keating EM, Faris PM. The effect of intraoperative intravenous fixed-dose heparin during total joint arthroplasty on the incidence of fatal pulmonary emboli. J Arthroplasty. 2000;15:16-21.
43. Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, Husslein P, Mannhalter C, Lechner K. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2001;21:874-879.
44. Pagnani MJ, Pellicci PM, Salvati EA. Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthrosis. J Bone Joint Surg. 1991;73:924-929.
45. Parks ML, Walsh HA, Salvati EA, Li S. Effect of increasing temperature on the properties of four bone cements. Clin Orthop Relat Res. 1998;355:238-248.
46. Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoli E, Baron JA, Harris WH, Poss R, Katz JN. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg. 2003;85:20-26.
47. Pitto RP, Blunk J, Kossler M. Transesophageal echocardiography and clinical features of fat embolism during cemented total hip arthroplasty: a randomized study in patients with a femoral neck fracture. Arch Orthop Trauma Surg. 2000;120:53-58.
48. Pitto RP, Hamer H, Fabiani R, Radespiel-Troeger M, Koessler M. Prophylaxis against fat and bone-marrow embolism during total hip arthroplasty reduces the incidence of postoperative deep-vein thrombosis: a controlled, randomized clinical trial. J Bone Joint Surg. 2002;84:39-48.
49. Pitto RP, Hamer H, Heiss-Dunlop W, Kuehle J. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement: a randomised clinical trial. J Bone Joint Surg. 2004;86:639-642.
50. Pitto RP, Kessler M, Schikora N, di Muria GV. The bone-vacuum cementing technique for the fixation of the stem in total hip arthroplasty. Chir Organi Mov. 2001;86:99-110.
51. Pitto RP, Koessler M, Draenert K. The John Charnley Award: Prophylaxis of fat and bone marrow embolism in cemented total hip arthroplasty. Clin Orthop Relat Res. 1998;355:23-34.
52. Planes A, Samama MM, Lensing AW, Buller HR, Barre J, Vochelle N, Beau B. Prevention of deep vein thrombosis after hip replacement: comparison between two low-molecular heparins, tinzaparin and enoxaparin. Thromb Haemost. 1999;81:22-25.
53. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. J Bone Joint Surg. 1990;72:9-13.
54. Ryan MG, Westrich GH, Potter HG, Sharrock N, Maun LM, Macaulay W, Katkin P, Sculco TP, Salvati EA. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg. 2002;84:1998-2004.
55. Salvati EA, Gonzalez Della Valle A. Thromboembolism following total hip replacement. J Long Term Eff Med Implants. 2003;13:325-340.
56. Salvati EA, Gonzalez Della Valle A, Westrich G, Rana A, Specht LM, Weksler BB, Wang P, Glueck CJ. The John Charnley Award: Heritable thrombophilia and development of thromboembolic disease following total hip arthroplasty. Clin Orthop Relat Res. 2005;441:40-55.
57. Salvati EA, Pellegrini VD Jr, Sharrock NE, Lotke PA, Murray DW, Potter H, Westrich GH. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg. 2000;82:252-270.
58. Salvati EA, Sharrock NE, Gonzalez Della Valle A. Current concepts in in the pathogenesis, diagnosis and multimodal prophylaxis of thromboembolism disease following total hip replacement. Minerva Ortopedica e Traumatologica. 2003;54:381-401.
59. Sanchez-Ballester J, Smith M, Hassan K, Kershaw S, Elsworth CS, Jacobs L. Wound infection in the management of hip fractures: a comparison between low-molecular weight heparin and mechanical prophylaxis. Acta Orthop Belg. 2005;71:55-59.
60. Sarmiento A, Goswami AD. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg. 1999;81:339-346.
61. Shaieb MD, Watson BN, Atkinson RE. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty. 1999;14:432-438.
62. Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K, Sculco TP. The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis: a randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg. 1990;72:1456-1461.
63. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA. The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res. 1995;319:16-27.
64. Sharrock NE, Go G, Sculco TP, Salvati EA, Westrich GH, Harpel PC. Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement. Anesthesiology. 1999;90:981-987.
65. Sharrock NE, Mineo R, Go G. The effect of cardiac output on intraoperative blood loss during total hip arthroplasty. Reg Anesth. 1993;18:24-29.
66. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg. 1993;76:580-584.
67. Sharrock NE, Ranawat CS, Urquhart B, Peterson M. Factors influencing deep vein thrombosis following total hip arthroplasty under epidural anesthesia. Anesth Analg. 1993;76:765-771.
68. Sharrock NE, Salvati EA. Hypotensive epidural anesthesia for total hip arthroplasty: a review. Acta Orthop Scand. 1996;67:91-107.
69. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis. 2003;14:469-477.
70. Srinivasan AF, Rice L, Bartholomew JR, Rangaswamy C, La Perna L, Thompson JE, Murphy S, Baker KR. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med. 2004;164:66-70.
71. Stamatakis JD, Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. BMJ. 1977;2:223-225.
72. Tejedor Alonso MA, Lopez Revuelta K, Garcia Bueno MJ, Casas Losada ML, Rosado Ingelmo A, Gruss Vergara E, Vila Albelda C, Moro Moro M. Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient. Clin Nephrol. 2005;63:236-240.
73. Veshchev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit. 2002;8:CS98-100.
74. Warkentin TE. Heparin-induced thrombocytopenia. Curr Hematol Rep. 2002;1:63-72.
75. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135:502-506.
76. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344:1286-1292.
77. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
78. Warwick D. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg. 1998;80:370-371.
79. Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement: a prospective, randomized trial. J Bone Joint Surg. 1998;80:1158-1166.
80. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg. 1995;77:6-10.
81. Watts AC, Brenkel IJ. A postal survey of current thromboprophylaxis practices of consultant orthopaedic surgeons in the treatment of fractures of the hip. J Bone Joint Surg. 2005;87:296-300.
82. Westrich GH, Farrell C, Bono JV, Ranawat CS, Salvati EA, Sculco TP. The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplasty. 1999;14:456-463.
83. Westrich GH, Rana AJ, Terry MA, Taveras NA, Kapoor K, Helfet DL. Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. J Orthop Trauma. 2005;19:234-240.
84. Westrich GH, Specht LM, Sharrock NE, Sculco TP, Salvati EA, Pellicci PM, Trombley JF, Peterson M. Pneumatic compression hemodynamics in total hip arthroplasty. Clin Orthop Relat Res. 2000;372:180-191.
85. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg. 2002;84:2161-2167.
86. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446-455.
87. Wille-Jorgensen P, Christensen SW, Bjerg-Nielsen A, Stadeager C, Kjaer L. Prevention of thromboembolism following elective hip surgery: the value of regional anesthesia and graded compression stockings. Clin Orthop Relat Res. 1989;247:163-167.
88. Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults: a randomized trial. JAMA. 1995;274:44-50.
89. Butt AJ, McCarthy T, Kelly IP, Glynn T, McCoy G. Sciatic nerve palsy secondary to post-operative hematoma in primary total hip replacement. J Bone Joint Surg Br. 2005;87:1465-1467.
90. Pellegrini VD, Donaldson CT, Farber DC, Lehman EB, McCollister Evarts C. The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop. 2005;441:56-62.